Clinical Trial Update: Effect of Albendazole Dose on Treatment of Lymphatic Filariasis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessed how different doses of albendazole influence treatment outcomes for lymphatic filariasis; the study completed and results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphatic Filariasis

Drugs mentioned

• Albendazole (ALBENDAZOLE)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Lymphatic Filariasis | Phase 2 | Status: COMPLETED | Results posted: 2015-08-31